13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q1 2017. See the latest, Q3 2026 →
Reported value
$8.49B
+11% on the quarter before
Positions
43
5 new, 6 sold out
Top 10
68.7%
of the value
Est. gain
+$414.1M
on stocks held all quarter
Est. return
+6.4%
on those stocks since Q4 2016
Positions as of Mar 31, 2017, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.
Largest buys
Since Q4 2016, sized at quarter-end prices.
- Colony Northstar Inc~$618.5MNew, 0.0% → 7.3% of the portfolio+47,905,461 shares
- Qorvo~$492.6MNew, 0.0% → 5.8% of the portfolio+7,185,514 shares
- Qualcomm~$299.1MNew, 0.0% → 3.5% of the portfolio+5,216,000 shares
- Express Scripts Hldg Co~$81.0MNew, 0.0% → 1.0% of the portfolio+1,228,619 shares
- Silver Run Acquisition~$69.0MNew, 0.0% → 0.8% of the portfolio+6,615,554 shares
- Cascadian Therapeutics Inc~$18.9MAdded, 0.2% → 0.4% of the portfolio+4,554,413 shares
- Forward Pharma A/S~$4.5MAdded, 1.0% → 1.4% of the portfolio+208,107 shares
Largest sells
Since Q4 2016, sized at quarter-end prices.
- Northstar Asset Mgmt Group I~$279.1MSold out, 3.6% → 0.0% of the portfolio−18,705,000 shares
- Allergan Plc~$238.9MCut, 9.4% → 6.8% of the portfolio−1,000,000 shares
- Northstar Rlty Fin Corp~$220.8MSold out, 2.9% → 0.0% of the portfolio−14,577,134 shares
- Colony Cap Inc~$140.9MSold out, 1.8% → 0.0% of the portfolio−6,959,017 shares
- Synchrony Finl~$102.9MCut, 9.8% → 7.1% of the portfolio−3,000,000 shares
- Dell Technologies Inc~$64.1MCut, 4.8% → 4.3% of the portfolio−1,000,000 shares
- Innoviva Inc~$46.4MCut, 2.1% → 1.9% of the portfolio−3,357,820 shares
- American Intl Group Inc~$28.5MCut, 0.8% → 0.3% of the portfolio−1,335,305 shares
- Liberty Media Corp Delaware~$23.6MCut, 0.8% → 0.6% of the portfolio−1,000,000 shares
- Theravance Inc~$22.6MCut, 0.5% → 0.3% of the portfolio−23,750,000 shares
Holdings
As of Mar 31, 2017; changes in shares since Dec 31, 2016.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Cheniere Energy IncCOM NEW · shares 0% · price +14.1% | 12.1% | $1.03B | +$126.9M | ||||||
| Viasat IncCOM · shares 0% · price −3.6% | 9.9% | $839.8M | −$31.6M | ||||||
| Twenty First Centy Fox IncCL A · shares 0% · price +15.5% | 7.3% | $619.9M | +$83.2M | ||||||
| Colony Northstar IncCL A COM · shares New | 7.3% | $618.5M | — | ||||||
| Synchrony FinlCOM · shares −15% · price −5.4% | 7.1% | $605.9M | −$34.8M | ||||||
| Allergan PlcSHS · shares −29% · price +13.8% | 6.8% | $581.2M | +$70.3M | ||||||
| QorvoCOM · shares New | 5.8% | $492.6M | — | ||||||
| Dell Technologies IncCOM CL V · shares −15% · price +16.6% | 4.3% | $362.2M | +$51.5M | ||||||
| Pbf Energy IncCL A · shares 0% · price −20.5% | 4.1% | $348.6M | −$89.8M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price +15.5% | 4.0% | $341.5M | +$45.8M | ||||||
| Antero Res CorpCOM · shares 0% · price −3.6% | 3.9% | $330.9M | −$12.2M | ||||||
| QualcommCOM · shares New | 3.5% | $299.1M | — | ||||||
| Twenty First Centy Fox IncCL B · shares 0% · price +16.6% | 2.7% | $231.3M | +$33.0M | ||||||
| Innoviva IncCOM · shares −22% · price +29.3% | 1.9% | $160.1M | +$36.2M | ||||||
| Keryx Biopharmaceuticals IncCOM · shares 0% · price +5.1% | 1.9% | $158.9M | +$7.7M | ||||||
| Veritiv CorpCOM · shares 0% · price −3.6% | 1.9% | $157.7M | −$5.9M | ||||||
| Mckesson CorpCOM · shares 0% · price +5.6% | 1.7% | $148.3M | +$7.8M | ||||||
| Forward Pharma A/SSPONSORED ADR · shares +3.9% · price +43.4% | 1.4% | $119.9M | +$34.9M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price +44.7% | 1.3% | $110.1M | +$34.0M | ||||||
| Cardinal Health IncCOM · shares 0% · price +13.3% | 0.99% | $84.0M | +$9.9M | ||||||
| Express Scripts Hldg CoCOM · shares New | 0.95% | $81.0M | — | ||||||
| Silver Run AcquisitionUNIT 99/99/9999 · shares New | 0.81% | $69.0M | — | ||||||
| Liberty Interactive CorpLBT VEN COM A NE · shares 0% · price +20.6% | 0.78% | $65.9M | +$11.3M | ||||||
| ChipMOS TechnologiesSPONSORED ADR · shares 0% · price +25.8% | 0.73% | $62.3M | +$12.8M | ||||||
| Credit Accep Corp MichCOM · shares 0% · price −8.3% | 0.57% | $48.7M | −$4.4M | ||||||
| Total 43 positions | 100% | $8.49B | +$414.1M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2016 to Q1 2017: 36 stocks held throughout, up $414.1M (+6.4%).
- Cheniere Energy Inc+$126.9M+14%
- Twenty First Centy Fox Inc+$83.2M+16%
- Allergan Plc+$70.3M+14%
- Dell Technologies Inc+$51.5M+17%
- Theravance Biopharma Inc+$45.8M+15%
- Veritiv Corp−$5.9M−4%
- Antero Res Corp−$12.2M−4%
- Viasat Inc−$31.6M−4%
- Synchrony Finl−$34.8M−5%
- Pbf Energy Inc−$89.8M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |